Page last updated: 2024-10-26

valproic acid and Hemoglobinopathies

valproic acid has been researched along with Hemoglobinopathies in 3 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Hemoglobinopathies: A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.

Research Excerpts

ExcerptRelevanceReference
"Aspirin was shown to increase oxygen affinity of hemoglobin via acetylating lysine residues and its general acetylating activity on proteins such as histones makes it also an interesting candidate to activate fetal hemoglobin."5.34Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale. ( Altinoz, MA; Carin, MN; Gedikoglu, G; Ozdilli, K, 2007)
" The fact that valproic acid, a derivative of pentanoic acid, also induces gamma-globin expression suggests that short-chain fatty acid derivatives that are already approved for human use may possess the property of gamma-globin inducibility and may be of therapeutic relevance to the beta-chain hemoglobinopathies."3.69Stimulation of fetal hemoglobin production by short chain fatty acids. ( Blau, CA; Dover, G; Fournarakis, B; Josephson, B; Li, Q; Liakopoulou, E; Papayannopoulou, T; Raisys, V; Stamatoyannopoulos, G; Wolf, JA, 1995)
"Aspirin was shown to increase oxygen affinity of hemoglobin via acetylating lysine residues and its general acetylating activity on proteins such as histones makes it also an interesting candidate to activate fetal hemoglobin."1.34Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale. ( Altinoz, MA; Carin, MN; Gedikoglu, G; Ozdilli, K, 2007)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okhovat, MA1
Ziari, K1
Ranjbaran, R1
Nikouyan, N1
Altinoz, MA1
Ozdilli, K1
Carin, MN1
Gedikoglu, G1
Liakopoulou, E1
Blau, CA1
Li, Q1
Josephson, B1
Wolf, JA1
Fournarakis, B1
Raisys, V1
Dover, G1
Papayannopoulou, T1
Stamatoyannopoulos, G1

Other Studies

3 other studies available for valproic acid and Hemoglobinopathies

ArticleYear
The effect of histone deacetylase inhibitors on AHSP expression.
    PloS one, 2018, Volume: 13, Issue:2

    Topics: Blood Proteins; Gene Expression Regulation; Hemoglobinopathies; Histone Deacetylase Inhibitors; Huma

2018
Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale.
    Medical hypotheses, 2007, Volume: 68, Issue:6

    Topics: Aspirin; Blood Transfusion, Intrauterine; Dose-Response Relationship, Drug; Drug Therapy, Combinatio

2007
Stimulation of fetal hemoglobin production by short chain fatty acids.
    Blood, 1995, Oct-15, Volume: 86, Issue:8

    Topics: Adult; Anemia, Sickle Cell; Animals; Anticonvulsants; Butyrates; Butyric Acid; Cells, Cultured; Epil

1995